Harbour BioMed Receives Chinese Regulatory Approval of IND Application to Begin Seamless Phase 2/3 Clinical Trial of HBM9161 in Immune Thrombocytopenia Life Science
Healthcare Roundup – Teladoc services surged in Q1 due to COVID-19, Sonnet BioTherapeutics up 87% Life Science
Technology Roundup – Apple launches virus-tracking tool, Nvidia-Mellanox deal nears Chinese approval Technology
Healthcare Roundup – Feds turn on funding spigot with $30B, Study shows viability of saliva testing for COVID-19 Life Science
Technology Roundup – Amazon reopens nonessential shipments, Alibaba target raised on e-commerce recovery Technology
Healthcare Roundup –Fauci hopes to see steps to normalization by summer, Pfizer identifies lead COVID-19 candidate Life Science
Technology Roundup –Alibaba’s H2 trending better than feared, Apple’s U.S. iPhone sales take hit Technology